MEDP - Medpace Holdings, Inc.
NEXT EARNINGS:
Apr 20, 2026
(in 23 days)
EPS Est: $3.94
|
Rev Est: $697.8M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$534.17
DETAILS
HIGH:
$582.00
LOW:
$460.00
MEDIAN:
$549.50
CONSENSUS:
$534.17
UPSIDE:
18.39%
Market Cap:
12.81B
Volume:
207,204
Avg Volume:
333,871
52 Week Range:
250.05-628.916
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.46
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
5,900
IPO Date:
2016-08-11
EPS (TTM):
15.66
P/E Ratio:
28.81
Revenue (TTM):
2.53B
Total Assets:
1.98B
Total Debt:
250.50M
Cash & Equiv:
497.05M
Rev Growth (5Y):
22.3%
EPS Growth (5Y):
30.9%
FCF Growth (5Y):
24.6%
ROCE:
85.9%
Debt/Equity:
0.55
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-09 | $4.67 | $4.19 | +11.5% | $708.5M | $689.3M | +2.8% |
| 2025-10-22 | $3.86 | $3.53 | +9.3% | $659.9M | $641.0M | +2.9% |
| 2025-07-21 | $3.10 | $2.98 | +4.0% | $603.3M | $538.8M | +12.0% |
| 2025-04-21 | $3.67 | $3.06 | +19.9% | $558.6M | $526.3M | +6.1% |
| 2025-02-10 | $3.67 | $2.96 | +24.0% | $536.6M | $539.7M | -0.6% |
| 2024-10-21 | $3.01 | $2.78 | +8.3% | $533.3M | $534.9M | -0.3% |
| 2024-07-22 | $2.75 | $2.54 | +8.3% | $528.1M | $528.4M | 0.0% |
| 2024-04-22 | $3.20 | $2.47 | +29.6% | $511.0M | $512.4M | -0.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.11B | 1.89B | 1.46B | 1.14B | 925.92M | 860.97M | 704.59M | 436.15M | 421.58M | 359.06M | 290.04M |
| Net Income | 451.12M | 404.39M | 282.81M | 245.37M | 181.85M | 145.38M | 100.44M | 73.19M | 39.12M | 13.43M | (8.67M) | (15.57M) |
| EPS | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 | -0.28 | -0.53 |
| Total Assets | 1.98B | 2.10B | 1.66B | 1.35B | 1.66B | 1.39B | 1.14B | 967.93M | 950.72M | 979.11M | 984.04M | 1.10B |
| Total Debt | 250.50M | 149.52M | 142.12M | 188.87M | 130.97M | 115.14M | 45.21M | 79.72M | 221.61M | 163.64M | 377.94M | 491.52M |
| Cash & Equivalents | 497.05M | 669.44M | 245.45M | 28.27M | 461.30M | 277.77M | 131.92M | 23.27M | 26.48M | 37.10M | 14.88M | 54.28M |
| Operating Cash Flow | 713.22M | 608.82M | 433.37M | 388.05M | 263.33M | 258.68M | 201.87M | 156.58M | 97.39M | 91.73M | 85.87M | 75.20M |
| Free Cash Flow | 681.87M | 572.27M | 396.73M | 351.17M | 235.06M | 227.34M | 183.96M | 140.56M | 85.09M | 78.19M | 79.41M | 69.89M |
| FCF per Share | 23.64 | 18.49 | 12.91 | 10.84 | 6.55 | 6.38 | 5.13 | 3.95 | 2.18 | 2.19 | 2.00 | 2.37 |
| Book Value | 459.07M | 825.54M | 558.95M | 386.39M | 952.93M | 805.78M | 726.28M | 589.70M | 503.53M | 610.71M | 413.47M | 401.97M |
| Cash & ST Investments | 497.05M | 669.44M | 245.45M | 28.27M | 461.30M | 277.77M | 131.92M | 23.27M | 26.48M | 37.10M | 14.88M | 54.28M |
| ROC Equity | 0.98 | 0.49 | 0.51 | 0.64 | 0.19 | 0.18 | 0.14 | 0.12 | 0.08 | 0.02 | -0.02 | -0.04 |